Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001294343-08-000016
Filing Date
2008-12-19
Accepted
2008-12-19 13:50:18
Documents
1
Period of Report
2008-12-18

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 13704
  Complete submission text file 0001294343-08-000016.txt   16828
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 1285 AVE OF THE AMERICAS 35TH FL. NEW YORK NY 10019
Business Address 1285 AVE OF THE AMERICAS 35TH FL. NEW YORK NY 10019 2125544158
SCO CAPITAL PARTNERS LLC (Reporting) CIK: 0001225978 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 081260249

Mailing Address C/O SCO CAPITAL PARTNERS LLC 1285 AVENUE OF THE AMERICAS 85TH FLOOR NEW YORK NY 10019
Business Address 212-554-4158
Rouhandeh Steven H (Reporting) CIK: 0001294343 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 081260248

Mailing Address 1285 AVE OF THE AMERICAS 35TH FL NEW YORK NY 10019
Business Address 1285 AVE OF THE AMERICAS 35TH FL NEW YORK NY 10019 212-554-4162
SCO CAPITAL PARTNERS L P (Reporting) CIK: 0001388286 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-15771 | Film No.: 081260250